1.09
Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten
Press Release Distribution & PR Platform - ACCESS Newswire
Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know - Yahoo Finance
Pacific Biosciences of California Selected by Davos Alzheimer's Collaborative as Technology Partner - marketscreener.com
PacBio partners with global Alzheimer’s initiative By Investing.com - Investing.com India
PacBio partners with global Alzheimer’s initiative - Investing.com Australia
PacBio (PACB) Joins DAC's North African Dementia Project | PACB Stock News - GuruFocus
PacBio Partners with Davos Alzheimer’s Collaborative to Advance Alzheimer's Research in North Africa - Nasdaq
Selling Pacific Biosciences of California Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders - simplywall.st
Positive week for Pacific Biosciences of California, Inc. (NASDAQ:PACB) institutional investors who lost 57% over the past year - Yahoo
Pacific Biosciences of California jumps 22% after prelim Q1 results, guides FY - MSN
Canaccord maintains $3 price target on PACB, reiterates Buy By Investing.com - Investing.com South Africa
Tariffs, NIH ‘uncertainty’ force PacBio into layoffsSan Francisco Business Times - The Business Journals
Canaccord maintains $3 price target on PACB, reiterates Buy - Investing.com
PacBio outlines cost-cutting, revenue meets Q1 target By Investing.com - Investing.com South Africa
PacBio to cut jobs, lower spending over NIH funding cuts and tariffs - Reuters
Healthcare Stocks Ride a Tariffs-Relief Wave -- Healthcare Roundup - marketscreener.com
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know - The Globe and Mail
Sequencing Company PacBio Cuts Costs Amid Uncertainty Around NIH Funding And New Tariffs - Benzinga
Simply Good Foods, Pacific Biosciences of California, Kura Sushi, Delta Air Lines And Other Big Stocks Moving Higher On Wednesday - Benzinga
Pacific Biosciences of California Sees Lower Q1 Revenue, Plans Job Cuts to Reduce Costs - MarketScreener
PacBio Q1 Prel. Revenue Down, Says Met Expectations; To Cut Jobs - Nasdaq
PacBio outlines cost-cutting, revenue meets Q1 target - Investing.com
Pacbio posts Preliminary Q1 2025 Revenue And Reiterates 2025 Revenue Guidance - marketscreener.com
Pacific Biosciences of California, Inc. Reiterates Earnings Guidance for the Full Year 2025 - marketscreener.com
PacBio's Bold Move: $50M Cost Cut Plan as Q1 Shows Record Consumables Growth - Stock Titan
PacBio Strengthens Leadership: New CFO Joins with Strategic Equity Package - Stock Titan
Customer success story: The University of Bern takes long-read sequencing to the next level with SPRQ chemistry - PacBio
Pacific Biosciences of California appoints CFO - MSN
PACB stock touches 52-week low at $1.15 amid market challenges - Investing.com
PacBio names Jim Gibson as new CFO By Investing.com - Investing.com South Africa
Pacific Biosciences of California Names Jim Gibson CFO - Marketscreener.com
PacBio names Jim Gibson as new CFO - Investing.com
Jim Gibson To Join PacBio As Chief Financial Officer - MarketScreener
Jim Gibson to join PacBio as Chief Financial Officer - GlobeNewswire
Tech Giant CFO Who Raised $1B+ Joins PacBio: Ex-Tesla, Apple Executive to Drive Growth - Stock Titan
Publications March 2025 - Pacific Biosciences
Pacific Biosciences Names Jim Gibson Chief Financial Officer - MarketWatch
Assessing Pacific Biosciences: Insights From 6 Financial Analysts - Benzinga
ATTENTION PACB SHAREHOLDERS: Investors Who Lost Money on Pacific Biosciences of California, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - ACCESS Newswire
Here's Why You Should Retain PacBio Stock in Your Portfolio Now - MSN
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Benzinga
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors - MSN
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now - MSN
PacBio, Take2 Resolve DNA Sequencing Patent Infringement Dispute - Bloomberg Law News
Is Pacific Biosciences of California, Inc. (PACB) the Most Volatile Stock Under $3 For Day Trading? - Insider Monkey
10 Most Volatile Stocks Under $3 For Day Trading - Insider Monkey
Inspiring the next generation of scientists: How multidisciplinary science powers PacBio technology - Pacific Biosciences
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):